orlistat and Renal-Insufficiency--Chronic

orlistat has been researched along with Renal-Insufficiency--Chronic* in 3 studies

Reviews

1 review(s) available for orlistat and Renal-Insufficiency--Chronic

Article	Year
The obese uremic patient: a newcomer in the nephrology clinic? Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28 Suppl 4 Topics: Anti-Obesity Agents; Humans; Lactones; Nephrology; Obesity; Orlistat; Renal Insufficiency, Chronic; Uremia	2013

Other Studies

2 other study(ies) available for orlistat and Renal-Insufficiency--Chronic

Article	Year
When the Cause Is Not Crystal Clear. The New England journal of medicine, 2020, Jan-02, Volume: 382, Issue:1 Topics: Anti-Obesity Agents; Calcium Oxalate; Crystallization; Diagnosis, Differential; Female; Glomerular Filtration Rate; Humans; Hyperoxaluria; Hyperoxaluria, Primary; Kidney; Middle Aged; Orlistat; Renal Insufficiency; Renal Insufficiency, Chronic	2020
Orlistat-induced oxalate nephropathy: an under-recognised cause of chronic kidney disease. BMJ case reports, 2017, Nov-12, Volume: 2017 Two patients developed kidney failure due to oxalate deposition in the kidney while taking orlistat. Cessation of orlistat was followed by partial recovery of kidney function. The mechanism by which orlistat causes hyperoxaluria and the management of orlistat-induced oxalate nephropathy is reviewed. We suggest that all patients taking orlistat are at risk of this condition, which may develop insidiously and is easily overlooked. Monitoring of kidney function of patients taking orlistat is warranted. Topics: Aged; Anti-Obesity Agents; Calcium Oxalate; Female; Humans; Hyperoxaluria; Kidney Tubular Necrosis, Acute; Lactones; Male; Microscopy; Obesity; Orlistat; Renal Insufficiency, Chronic	2017

Article

Year

When the Cause Is Not Crystal Clear.

The New England journal of medicine, 2020, Jan-02, Volume: 382, Issue:1

Topics: Anti-Obesity Agents; Calcium Oxalate; Crystallization; Diagnosis, Differential; Female; Glomerular Filtration Rate; Humans; Hyperoxaluria; Hyperoxaluria, Primary; Kidney; Middle Aged; Orlistat; Renal Insufficiency; Renal Insufficiency, Chronic

2020

Orlistat-induced oxalate nephropathy: an under-recognised cause of chronic kidney disease.

BMJ case reports, 2017, Nov-12, Volume: 2017

Two patients developed kidney failure due to oxalate deposition in the kidney while taking orlistat. Cessation of orlistat was followed by partial recovery of kidney function. The mechanism by which orlistat causes hyperoxaluria and the management of orlistat-induced oxalate nephropathy is reviewed. We suggest that all patients taking orlistat are at risk of this condition, which may develop insidiously and is easily overlooked. Monitoring of kidney function of patients taking orlistat is warranted.

Topics: Aged; Anti-Obesity Agents; Calcium Oxalate; Female; Humans; Hyperoxaluria; Kidney Tubular Necrosis, Acute; Lactones; Male; Microscopy; Obesity; Orlistat; Renal Insufficiency, Chronic

2017